Hester Biosciences Limited has submitted a regulatory intimation regarding an upcoming board meeting scheduled for Thursday, 5 November 2026. The primary purpose of this meeting is to consider and approve the company's unaudited standalone and consolidated financial results for the quarter ended 30 September 2026 and the six-month period ended 30 September 2026.
The communication was digitally signed by Vinod Mali, who holds the positions of Company Secretary and Compliance Officer for Hester Biosciences Limited. The signing timestamp was recorded as 27 October 2026 at 14:17:13 +05:30.
No specific financial figures, performance metrics, or operational updates were disclosed in this intimation, which serves solely as a notice of the upcoming board meeting agenda.